Pan-Cancer Analysis and Drug Formulation for GPR139 and GPR142

Overview

Journal Front Pharmacol

Date 2021 Mar 8

PMID 33679382

Citations 3

Authors

Aman Chandra Kaushik

Aamir Mehmood

Xiaofeng Dai

Dong-Qing Wei

Affiliations

Soon will be listed here.

Abstract

GPR (G protein receptor) 139 and 142 are novel foundling GPCRs (G protein-coupled receptors) in the class "A" of the GPCRs family and are suitable targets for various biological conditions. To engage these targets, validated pharmacophores and 3D QSAR (Quantitative structure-activity relationship) models are widely used because of their direct fingerprinting capability of the target and an overall accuracy. The current work initially analyzes GPR139 and GPR142 for its genomic alteration via tumor samples. Next to that, the pharmacophore is developed to scan the 3D database for such compounds that can lead to potential agonists. As a result, several compounds have been considered, showing satisfactory performance and a strong association with the target. Additionally, it is gripping to know that the obtained compounds were observed to be responsible for triggering pan-cancer. This suggests the possible role of novel GPR139 and GPR142 as the substances for initiating a physiological response to handle the condition incurred as a result of cancer.

Citing Articles

Multiomics dynamic learning enables personalized diagnosis and prognosis for pancancer and cancer subtypes.

Lu Y, Peng R, Dong L, Xia K, Wu R, Xu S Brief Bioinform. 2023; 24(6).

PMID: 37889117 PMC: 10605059. DOI: 10.1093/bib/bbad378.

Therapeutic and prognostic potential of GPCRs in prostate cancer from multi-omics landscape.

Li S, Chen J, Chen X, Yu J, Guo Y, Li M Front Pharmacol. 2022; 13:997664.

PMID: 36110544 PMC: 9468875. DOI: 10.3389/fphar.2022.997664.

Evidence of Omics, Immune Infiltration, and Pharmacogenomic for SENP1 in the Pan-Cancer Cohort.

Taghvaei S, Sabouni F, Minuchehr Z Front Pharmacol. 2021; 12:700454.

PMID: 34276383 PMC: 8280523. DOI: 10.3389/fphar.2021.700454.

References

John S, Thangapandian S, Arooj M, Hong J, Kim K, Lee K . Development, evaluation and application of 3D QSAR Pharmacophore model in the discovery of potential human renin inhibitors. BMC Bioinformatics. 2012; 12 Suppl 14:S4. PMC: 3287469. DOI: 10.1186/1471-2105-12-S14-S4. View

Wang Q, Mehmood A, Wang H, Xu Q, Xiong Y, Wei D . Computational Screening and Analysis of Lung Cancer Related Non-Synonymous Single Nucleotide Polymorphisms on the Human Kirsten Rat Sarcoma Gene. Molecules. 2019; 24(10). PMC: 6572712. DOI: 10.3390/molecules24101951. View

Korber B, LaBute M, Yusim K . Immunoinformatics comes of age. PLoS Comput Biol. 2006; 2(6):e71. PMC: 1484584. DOI: 10.1371/journal.pcbi.0020071. View

Mehmood A, Kaushik A, Wei D . Prediction and validation of potent peptides against herpes simplex virus type 1 via immunoinformatic and systems biology approach. Chem Biol Drug Des. 2019; 94(5):1868-1883. DOI: 10.1111/cbdd.13602. View

Du X, Kim Y, Lai S, Chen X, Lizarzaburu M, Turcotte S . Phenylalanine derivatives as GPR142 agonists for the treatment of type II diabetes. Bioorg Med Chem Lett. 2012; 22(19):6218-23. DOI: 10.1016/j.bmcl.2012.08.015. View

Khan A, Junaid M, Kaushik A, Ali A, Ali S, Mehmood A . Computational identification, characterization and validation of potential antigenic peptide vaccines from hrHPVs E6 proteins using immunoinformatics and computational systems biology approaches. PLoS One. 2018; 13(5):e0196484. PMC: 5929558. DOI: 10.1371/journal.pone.0196484. View

Bhachoo J, Beuming T . Investigating Protein-Peptide Interactions Using the Schrödinger Computational Suite. Methods Mol Biol. 2017; 1561:235-254. DOI: 10.1007/978-1-4939-6798-8_14. View

Trott O, Olson A . AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2009; 31(2):455-61. PMC: 3041641. DOI: 10.1002/jcc.21334. View

Shivakumar D, Williams J, Wu Y, Damm W, Shelley J, Sherman W . Prediction of Absolute Solvation Free Energies using Molecular Dynamics Free Energy Perturbation and the OPLS Force Field. J Chem Theory Comput. 2015; 6(5):1509-19. DOI: 10.1021/ct900587b. View

10.

Schneider , Neidhart , Giller , SCHMID . "Scaffold-Hopping" by Topological Pharmacophore Search: A Contribution to Virtual Screening. Angew Chem Int Ed Engl. 1999; 38(19):2894-2896. View

11.

Junaid M, Shah M, Khan A, Li C, Khan M, Kaushik A . Structural-dynamic insights into the cytotoxin-associated gene A (CagA) and its abrogation to interact with the tumor suppressor protein ASPP2 using decoy peptides. J Biomol Struct Dyn. 2018; 37(15):4035-4050. DOI: 10.1080/07391102.2018.1537895. View

12.

Dixon S, Smondyrev A, Rao S . PHASE: a novel approach to pharmacophore modeling and 3D database searching. Chem Biol Drug Des. 2006; 67(5):370-2. DOI: 10.1111/j.1747-0285.2006.00384.x. View

13.

Roy U, Luck L . Molecular modeling of estrogen receptor using molecular operating environment. Biochem Mol Biol Educ. 2011; 35(4):238-43. DOI: 10.1002/bmb.65. View

14.

Kim S, Thiessen P, Bolton E, Chen J, Fu G, Gindulyte A . PubChem Substance and Compound databases. Nucleic Acids Res. 2015; 44(D1):D1202-13. PMC: 4702940. DOI: 10.1093/nar/gkv951. View

15.

Mitra I, Saha A, Roy K . Pharmacophore mapping of arylamino-substituted benzo[b]thiophenes as free radical scavengers. J Mol Model. 2010; 16(10):1585-96. DOI: 10.1007/s00894-010-0661-4. View

16.

Atanes P, Ruz-Maldonado I, Hawkes R, Liu B, Zhao M, Huang G . Defining G protein-coupled receptor peptide ligand expressomes and signalomes in human and mouse islets. Cell Mol Life Sci. 2018; 75(16):3039-3050. PMC: 6061145. DOI: 10.1007/s00018-018-2778-z. View

17.

Lee K, Briggs J . Comparative molecular field analysis (coMFA) study of epothilones-tubulin depolymerization inhibitors: pharmacophore development using 3D QSAR methods. J Comput Aided Mol Des. 2001; 15(1):41-55. DOI: 10.1023/a:1011140723828. View

18.

Wadood A, Mehmood A, Khan H, Ilyas M, Ahmad A, Alarjah M . Epitopes based drug design for dengue virus envelope protein: A computational approach. Comput Biol Chem. 2017; 71:152-160. DOI: 10.1016/j.compbiolchem.2017.10.008. View

19.

Sun H . Pharmacophore-based virtual screening. Curr Med Chem. 2008; 15(10):1018-24. DOI: 10.2174/092986708784049630. View

20.

Jiang Y . Molecular docking and 3D-QSAR studies on beta-phenylalanine derivatives as dipeptidyl peptidase IV inhibitors. J Mol Model. 2010; 16(7):1239-49. DOI: 10.1007/s00894-009-0637-4. View